Delivery Order SPE2DB20D6037-SPE2DB24FTVN4

Award Date 5/14/24
Potential Completion Date 5/15/24
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $2,067.00 and has a completion date of June 26, 2024. DMS Pharmaceutical Group will supply the DLA with 4564993076 units of Atovaquone-Proguanil 250-100mg tablets. This delivery order is issued under a larger indefinite delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $10,254.93, is for the delivery of atovaquone and progesterone pharmaceutical products to support the medical supply needs of military health facilities. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,455.38 firm fixed-price contract is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract has an ultimate completion date of November 5, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $3,810.60 firm fixed-price contract is for the delivery of Atovaquone-Proguanil 250-100 tablets. The contract has no set-aside designation and is issued under DMS Pharmaceutical Group's indefinite delivery contract SPE2DB24D9131 with the DLA, which has a ceiling value of up to $4,999,999 through 2025. This indefinite delivery vehicle enables the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,612.71, is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S medication. It is a firm fixed-price contract with no set-aside designation. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This is a delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $1,396.19, is for the supply of the pharmaceutical product atovaquone/proguanil. The overall SPE2DB contract is an indefinite-delivery, indefinite-quantity (IDIQ) vehicle with a ceiling value of up to $499,999,999, which allows the DLA to issue firm fixed-price...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of Atovaquone-Proguanil 250-100mg tablets. The contract has a completion date of February 14, 2024 and a potential value of $1,929.20. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDV) 4600082013 with the Defense Logistics Agency, valued at up to...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $71,751.90 under an indefinite delivery contract with the Defense Logistics Agency to supply the pharmaceutical items Atovaquone and Proguanil. As a woman-owned small business, DMS Pharmaceutical Group will provide these medications to fulfill requirements at Defense Logistics Agency Troop Support Medical facilities. Under the larger indefinite delivery contract valued at up to $5 million through December...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of atovaquone-proguanil 250-100mg tablets. The total potential value of this order is $2,883.10. DMS Pharmaceutical Group holds an indefinite delivery contract with the Defense Logistics Agency to provide a variety of pharmaceutical and medical supplies, including items like atropine, heparin, and Narcan nasal spray, to...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $3,913.74 under an indefinite delivery contract with the Defense Logistics Agency to supply the pharmaceutical items Atovaquone and Proguanil. As a woman-owned small business, DMS Pharmaceutical Group will provide these medications to fulfill requirements for Defense Logistics Agency Troop Support Medical. DMS Pharmaceutical Group currently supplies various pharmaceuticals and medical products to support...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB24FTVN4
    Delivery Order

This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $3,440.10 firm fixed-price contract is for the delivery of 4564593533 - Atovaquone-Proguanil 250-100 UD 24S to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract with DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical items. This contract has no set-aside designation.

Generated 10/23/24, 9:27 AM